Global Biodefense Market Growth 2019-2024

  • ID:PD040947
  • February 2019
  • LPI (LP Information)
                          

The Global Biodefense Market Research Report available with DecisionDatabases.com explores the market statistics between 2019 to 2024. The historic data of Biodefense market size, market share, revenue, consumption, sales has been gathered, analysed and compiled in this report assuring high quality and precision. The future trends are explored under the guidance of industry experts and analysts. The forecast trends and Biodefense industry outlook will assist opportunists with ideal information and data to take an informed decision.

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.

By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.

In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.

According to this study, over the next five years the Biodefense market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 1390 million by 2024, from US$ 850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biodefense business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key manufacturers and key regions and countries.

This study considers the Biodefense value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  Anthrax
  •  Smallpox
  •  Botulism
  •  Radiation/Nuclear
  •  Others
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  US Military Market
  •  US Civilian Market
  •  Non - US Market

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Emergent Biosolutions
  •  Hytest
  •  GSK
  •  Sanofi
  •  PharmAthene
  •  Bavarian Nordic
  •  SIGA Technologies
  •  Arbutus Biopharma
  •  DynPort Vaccine
  •  Xoma Corporation
  •  Ichor Medical Systems
  •  Aeolus Pharmaceuticals
  •  Achaogen
  •  Elusys Therapeutics
  •  Dynavax Technologies
  •  Cleveland BioLabs
  •  Soligenix
  •  Alnylam Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global Biodefense consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of Biodefense market by identifying its various subsegments.
  •  Focuses on the key global Biodefense manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the Biodefense with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of Biodefense submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biodefense Consumption 2014-2024
2.1.2 Biodefense Consumption CAGR by Region
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Consumption by Type
2.3.1 Global Biodefense Consumption Market Share by Type (2014-2019)
2.3.2 Global Biodefense Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biodefense Sale Price by Type (2014-2019)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Consumption by Application
2.5.1 Global Biodefense Consumption Market Share by Application (2014-2019)
2.5.2 Global Biodefense Value and Market Share by Application (2014-2019)
2.5.3 Global Biodefense Sale Price by Application (2014-2019)
 
3 Global Biodefense by Players
3.1 Global Biodefense Sales Market Share by Players
3.1.1 Global Biodefense Sales by Players (2017-2019)
3.1.2 Global Biodefense Sales Market Share by Players (2017-2019)
3.2 Global Biodefense Revenue Market Share by Players
3.2.1 Global Biodefense Revenue by Players (2017-2019)
3.2.2 Global Biodefense Revenue Market Share by Players (2017-2019)
3.3 Global Biodefense Sale Price by Players
3.4 Global Biodefense Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biodefense Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biodefense Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 Biodefense by Regions
4.1 Biodefense by Regions
4.1.1 Global Biodefense Consumption by Regions
4.1.2 Global Biodefense Value by Regions
4.2 Americas Biodefense Consumption Growth
4.3 APAC Biodefense Consumption Growth
4.4 Europe Biodefense Consumption Growth
4.5 Middle East & Africa Biodefense Consumption Growth
 
5 Americas
5.1 Americas Biodefense Consumption by Countries
5.1.1 Americas Biodefense Consumption by Countries (2014-2019)
5.1.2 Americas Biodefense Value by Countries (2014-2019)
5.2 Americas Biodefense Consumption by Type
5.3 Americas Biodefense Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC Biodefense Consumption by Countries
6.1.1 APAC Biodefense Consumption by Countries (2014-2019)
6.1.2 APAC Biodefense Value by Countries (2014-2019)
6.2 APAC Biodefense Consumption by Type
6.3 APAC Biodefense Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe Biodefense by Countries
7.1.1 Europe Biodefense Consumption by Countries (2014-2019)
7.1.2 Europe Biodefense Value by Countries (2014-2019)
7.2 Europe Biodefense Consumption by Type
7.3 Europe Biodefense Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa Biodefense by Countries
8.1.1 Middle East & Africa Biodefense Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Biodefense Value by Countries (2014-2019)
8.2 Middle East & Africa Biodefense Consumption by Type
8.3 Middle East & Africa Biodefense Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biodefense Distributors
10.3 Biodefense Customer
 
11 Global Biodefense Market Forecast
11.1 Global Biodefense Consumption Forecast (2019-2024)
11.2 Global Biodefense Forecast by Regions
11.2.1 Global Biodefense Forecast by Regions (2019-2024)
11.2.2 Global Biodefense Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biodefense Forecast by Type
11.8 Global Biodefense Forecast by Application
 
12 Key Players Analysis
12.1 Emergent Biosolutions
12.1.1 Company Details
12.1.2 Biodefense Product Offered
12.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Emergent Biosolutions News
12.2 Hytest
12.2.1 Company Details
12.2.2 Biodefense Product Offered
12.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Hytest News
12.3 GSK
12.3.1 Company Details
12.3.2 Biodefense Product Offered
12.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 GSK News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Biodefense Product Offered
12.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 PharmAthene
12.5.1 Company Details
12.5.2 Biodefense Product Offered
12.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 PharmAthene News
12.6 Bavarian Nordic
12.6.1 Company Details
12.6.2 Biodefense Product Offered
12.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Bavarian Nordic News
12.7 SIGA Technologies
12.7.1 Company Details
12.7.2 Biodefense Product Offered
12.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 SIGA Technologies News
12.8 Arbutus Biopharma
12.8.1 Company Details
12.8.2 Biodefense Product Offered
12.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Arbutus Biopharma News
12.9 DynPort Vaccine
12.9.1 Company Details
12.9.2 Biodefense Product Offered
12.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 DynPort Vaccine News
12.10 Xoma Corporation
12.10.1 Company Details
12.10.2 Biodefense Product Offered
12.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Xoma Corporation News
12.11 Ichor Medical Systems
12.12 Aeolus Pharmaceuticals
12.13 Achaogen
12.14 Elusys Therapeutics
12.15 Dynavax Technologies
12.16 Cleveland BioLabs
12.17 Soligenix
12.18 Alnylam Pharmaceuticals
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..